BSE filing, NSE: CONTPTR. Summary written from the filing by ALFA Finder's alert engine.
Continental Petroleums Ltd: key numbers
- Share price
- ₹75.90
- Market cap
- ₹64.27 Cr
- Revenue (annual)
- ₹84.89 Cr
- Net profit (annual)
- ₹3.41 Cr
- P/E (TTM)
- 20.3×Sector 18.3×
- Promoter holding
- 28.47%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Continental Petroleums Ltd
All →Continental Petroleums Q2 FY27 Results: Net Profit ₹0.9 Cr, Down 18.2% YoY
Continental Petroleums Ltd reported revenue from operations of ₹26.5 Cr (+9.1% YoY) and net profit of ₹0.9 Cr (-18.2% YoY) for Q2 FY27.
- Key figure
- Net profit ₹0.9 Cr · -18.2% YoY
Continental Petroleums Board Meeting Date
Continental Petroleums intimated BSE that its board meets on 22/10/2026 to approve Q1 FY27 results. The trading window closed from 01/10/2026.
Continental Petroleums Annual General Meeting
Continental Petroleums Ltd held its 40th AGM on September 29, 2026, to discuss financial statements, director re-appointment, and secretarial auditor appointment.
Continental Petroleums Annual General Meeting
Continental Petroleums announced book closure dates from September 23–29, 2026, for its Annual General Meeting. September 22, 2026, is the cut-off date for remote e-voting.
Continental Petroleums Board Meeting Outcome
The Board fixed the 40th AGM for September 29, 2026, approved the Board Report, and appointed a scrutinizer for the upcoming e-voting process.
Continental Petroleums Board Meeting Date
Continental Petroleums Ltd will hold a Board Meeting on 05.09.2026 to approve the Board Report and notice for the 40th Annual General Meeting.
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.